F Breedveld

Summary

Affiliation: Leiden University
Country: The Netherlands

Publications

  1. ncbi Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine
    B E van den Borne
    Department of Rheumatology, Leiden University Hospital, The Netherlands
    J Rheumatol 25:1493-8. 1998
  2. ncbi New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis
    F Breedveld
    Department of Rheumatology, Leiden University Hospital, The Netherlands
    Eur Cytokine Netw 9:233-8. 1998
  3. ncbi Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline
    B E van den Borne
    Department of Rheumatology, Leiden University Medical Center, The Netherlands
    Clin Rheumatol 18:369-72. 1999
  4. ncbi Leflunomide: mode of action in the treatment of rheumatoid arthritis
    F C Breedveld
    Academic Ziekenhuis Leiden, Stafcentrum Reumatologie, Leiden, The Netherlands
    Ann Rheum Dis 59:841-9. 2000
  5. ncbi Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial
    W van der Laan
    Department of Rheumatology, Leiden University Medical Centre, The Netherlands
    J Rheumatol 28:1967-74. 2001
  6. ncbi Multiple faces of rheumatoid arthritis: diagnostic and therapeutic algorithms
    F Breedveld
    University Hospital, Department of Rheumatology, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    Autoimmun Rev 3:S22. 2004

Collaborators

  • A H Zwinderman
  • B E van den Borne
  • W van der Laan
  • J H Rietveld
  • R B Landewe
  • B A Dijkmans
  • H S Goei The
  • J Verheijen
  • R Greenwald
  • J TeKoppele
  • B Dijkmans
  • K Ronday
  • E Molenaar
  • E N Griep
  • G A Bruyn

Detail Information

Publications6

  1. ncbi Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine
    B E van den Borne
    Department of Rheumatology, Leiden University Hospital, The Netherlands
    J Rheumatol 25:1493-8. 1998
    ..To investigate whether there is interaction between chloroquine and cyclosporine (CyA) at the level of efficacy and toxicity in patients with recent onset rheumatoid arthritis (RA)...
  2. ncbi New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis
    F Breedveld
    Department of Rheumatology, Leiden University Hospital, The Netherlands
    Eur Cytokine Netw 9:233-8. 1998
    ..Trials with etanercept, which showed significant, rapid and sustained reductions in disease activity, have produced particularly encouraging results...
  3. ncbi Chloroquine therapy in patients with recent-onset rheumatoid arthritis: the clinical response can be predicted by the low level of acute-phase reaction at baseline
    B E van den Borne
    Department of Rheumatology, Leiden University Medical Center, The Netherlands
    Clin Rheumatol 18:369-72. 1999
    ..97 (95% confidence interval: 0.95-0.98)]. It was concluded that a clinical response to chloroquine therapy in early RA patients can be predicted by a low CRP level at baseline...
  4. ncbi Leflunomide: mode of action in the treatment of rheumatoid arthritis
    F C Breedveld
    Academic Ziekenhuis Leiden, Stafcentrum Reumatologie, Leiden, The Netherlands
    Ann Rheum Dis 59:841-9. 2000
    ..Continuing research indicates that A77 1726 may downregulate the glycosylation of adhesion molecules, effectively reducing cell-cell contact activation during inflammation...
  5. ncbi Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial
    W van der Laan
    Department of Rheumatology, Leiden University Medical Centre, The Netherlands
    J Rheumatol 28:1967-74. 2001
    ..CONCLUSION: The results indicate that 50 mg doxycycline twice a day provided no therapeutic benefit for patients with RA...
  6. ncbi Multiple faces of rheumatoid arthritis: diagnostic and therapeutic algorithms
    F Breedveld
    University Hospital, Department of Rheumatology, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    Autoimmun Rev 3:S22. 2004